ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 24 2025
0mins
Source: Globenewswire
Special Meeting of Stockholders: ReShape Lifesciences held a Special Meeting where proposals for the sale of assets to Ninjour Health International and charter amendments related to a merger with Vyome Therapeutics were partially adjourned, allowing more time for stockholder voting.
Voting Importance: Stockholders are urged to vote in favor of the Asset Sale and Charter Amendment Proposals, as their approval is crucial for the completion of the merger, with the meeting reconvening on August 7, 2025.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
